placement

This section is Partnership content providedThe content in this section is provided by GlobeNewswire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Globe Newswire…

This section is Partnership content providedThe content in this section is provided by GlobeNewswire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Globe Newswire…

This section is Partnership content providedThe content in this section is provided by GlobeNewswire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Globe Newswire…

(Reuters) - The Federal Court has dismissed an appeal by ANZ Group against a lawsuit that found the lender guilty of failing to disclose a A$2.5 billion (US$1.73 billion) share offering, Australia's corporate regulator said on Wednesday.…

HOUSTON – (Business): Crescent Energy Corporation (NYSE: CRGY) (we or our) today announced that its indirect subsidiary, Crescent Energy Finance LLC (the Issuer) has priced its previously announced private offering pursuant to Rule 144A…

This section is Partnership Content ProvidedThe content in this section has been provided by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Globe…

Article ContentTORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Limited (“Arch” or the “Company”) (TSE: ARCH and OTCQB: ACHFF) today announced that it has closed the unconsented private placement disclosed in a press release…

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire…

This section is Partnership content providedThe content in this section is provided by GlobeNewswire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Globe Newswire…

New York, May 16, 2024 /PRNewswire/ -- Selous Therapeutics (NASDAQ:), Inc. (Nasdaq: SEEL) (“Seelos” or the “Company”), a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system (“CNS”)…